End P - Search Results

1

Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.

Pan S, Gray NS, Gao W, Mi Y, Fan Y, Wang X, Tuntland T, Che J, Lefebvre S, Chen Y, Chu A, Hinterding K, Gardin A, End P, Heining P, Bruns C, Cooke NG, Nuesslein-Hildesheim B. Pan S, et al. Among authors: end p. ACS Med Chem Lett. 2013 Jan 4;4(3):333-7. doi: 10.1021/ml300396r. eCollection 2013 Mar 14. ACS Med Chem Lett. 2013. PMID: 24900670 Free PMC article.

2

Tenascin: a modulator of cell growth.

End P, Panayotou G, Entwistle A, Waterfield MD, Chiquet M. End P, et al. Eur J Biochem. 1992 Nov 1;209(3):1041-51. doi: 10.1111/j.1432-1033.1992.tb17380.x. Eur J Biochem. 1992. PMID: 1385122 Free article.

3

Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial.

Kaul M, End P, Cabanski M, Schuhler C, Jakab A, Kistowska M, Kinhikar A, Maiolica A, Sinn A, Fuhr R, Cenni B. Kaul M, et al. Among authors: end p. Clin Transl Sci. 2021 Sep;14(5):1756-1768. doi: 10.1111/cts.13005. Epub 2021 Apr 9. Clin Transl Sci. 2021. PMID: 33834628 Free PMC article. Clinical Trial.

4

Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach.

Panayotou G, Gish G, End P, Truong O, Gout I, Dhand R, Fry MJ, Hiles I, Pawson T, Waterfield MD. Panayotou G, et al. Among authors: end p. Mol Cell Biol. 1993 Jun;13(6):3567-76. doi: 10.1128/mcb.13.6.3567-3576.1993. Mol Cell Biol. 1993. PMID: 8388538 Free PMC article.

5

Domains of laminin with growth-factor activity.

Panayotou G, End P, Aumailley M, Timpl R, Engel J. Panayotou G, et al. Among authors: end p. Cell. 1989 Jan 13;56(1):93-101. doi: 10.1016/0092-8674(89)90987-2. Cell. 1989. PMID: 2491959

6

Characterization of the bovine brain cytosolic phosphatidylinositol 3-kinase complex.

Ruiz-Larrea F, Vicendo P, Yaish P, End P, Panayotou G, Fry MJ, Morgan SJ, Thompson A, Parker PJ, Waterfield MD. Ruiz-Larrea F, et al. Among authors: end p. Biochem J. 1993 Mar 1;290 ( Pt 2)(Pt 2):609-16. doi: 10.1042/bj2900609. Biochem J. 1993. PMID: 8383968 Free PMC article.

7

A biosensor approach to probe the structure and function of the p85 alpha subunit of the phosphatidylinositol 3-kinase complex.

End P, Gout I, Fry MJ, Panayotou G, Dhand R, Yonezawa K, Kasuga M, Waterfield MD. End P, et al. J Biol Chem. 1993 May 15;268(14):10066-75. J Biol Chem. 1993. PMID: 7683666 Free article.

8

SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

McGlade CJ, Ellis C, Reedijk M, Anderson D, Mbamalu G, Reith AD, Panayotou G, End P, Bernstein A, Kazlauskas A, et al. McGlade CJ, et al. Among authors: end p. Mol Cell Biol. 1992 Mar;12(3):991-7. doi: 10.1128/mcb.12.3.991-997.1992. Mol Cell Biol. 1992. PMID: 1372092 Free PMC article.

9

Riding the evanescent wave.

Panayotou G, Waterfield MD, End P. Panayotou G, et al. Among authors: end p. Curr Biol. 1993 Dec 1;3(12):913-5. doi: 10.1016/0960-9822(93)90236-h. Curr Biol. 1993. PMID: 15335835 No abstract available.

10

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug-drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling.

Huth F, Schiller H, Jin Y, Poller B, Schuhler C, Weis W, Woessner R, Drollmann A, End P. Huth F, et al. Among authors: end p. Clin Transl Sci. 2022 Jan;15(1):118-129. doi: 10.1111/cts.13126. Epub 2021 Aug 25. Clin Transl Sci. 2022. PMID: 34432364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page